Squarepoint
IXHL icon

Squarepoint’s Incannex Healthcare IXHL Stock Holding History

Squarepoint’s Portfolio IXHL Stock Details IXHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-357
Closed -$22.7K – 5014
2024
Q4 		$22.7K Sell
357
-14
-4% -$841 ﹤0.01% 4926
2024
Q3 		$22.2K Buy
+371
New +$22.9K ﹤0.01% 4016

Other funds holding IXHL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Squarepoint's IXHL Position: Q1 2025 in Review

Squarepoint sold out of Incannex Healthcare (IXHL) in Q1 2025, closing a stake of 357 shares — an estimated $22.7K sold.

Squarepoint first reported a position in IXHL in Q3 2024 and held it in 2 quarters. The position peaked at $22.7K in Q4 2024. 6 funds tracked by Wall St. Rank hold IXHL as of Q1 2025.

  • Squarepoint reported no remaining Incannex Healthcare position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 357 Incannex Healthcare shares in Q1 2025, an estimated $22.7K.
  • Squarepoint first reported a position in Incannex Healthcare in Q3 2024 and held it in 2 quarters.
  • Squarepoint's Incannex Healthcare position peaked at $22.7K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Incannex Healthcare as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.